Medications for Cholangiocarcinoma

2 results
  • pemazyre - pemigatinib tablet

    (Pemigatinib)
    Incyte Corporation
    Pemazyre treats adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement, and adults with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.
  • tibsovo - ivosidenib tablet, film coated

    (Ivosidenib)
    Servier Pharmaceutical Llc
    Tibsovo is an IDH1 inhibitor for adults with susceptible IDH1 mutations. Indicated for newly diagnosed AML in patients 75+ or unfit for intensive chemotherapy, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes, and previously treated locally advanced or metastatic cholangiocarcinoma.